Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00578630 · ClinicalTrials.gov registry record
Interindividual Genetic Variability as a Determinant of Chemotherapy Toxicity and Response in Pediatric Bone Marrow Transplantation Patients
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 128
- Enrollment target
NCT00578630: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00578630 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 128 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00578630 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 128 participants
- Enrollment target
Study Summary
The purpose of this study is to develop tests that will allow us to determine who will react differently to the drugs used to treat cancer. We also want to see who will react differently with preparing for a bone marrow transplant.
Interventions
- OTHER buccal swabs and obtaining peripheral blood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2003-10-14 |
| Est. Completion | 2018-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00578630
The ClinicalTrials.gov registry entry for NCT00578630 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 128 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which buccal swabs and obtaining peripheral blood is the first listed.
NCT00578630 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00578630 about?
NCT00578630 is a clinical study titled "Interindividual Genetic Variability as a Determinant of Chemotherapy Toxicity and Response in Pediatric Bone Marrow Transplantation Patients". The purpose of this study is to develop tests that will allow us to determine who will react differently to the drugs used to treat cancer. We also want to see who will react differently with preparing for a bone marrow transplant.
What is the current status of trial NCT00578630?
This trial is currently completed. The enrollment target is 128 participants. The study started on 2003-10-14. Estimated completion is 2018-11.
What interventions are being tested in trial NCT00578630?
The interventions under investigation include: buccal swabs and obtaining peripheral blood (OTHER).
Who is sponsoring clinical trial NCT00578630?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.